Ongoing compliance, vigilance, safety monitoring, reporting, and lifecycle support after market authorization.
Ongoing compliance, vigilance, safety monitoring, reporting, and lifecycle support after market authorization.





Clear outputs that drive compliance, reduce risk, and accelerate your time to market.
A structured surveillance plan defining scope, data sources, and responsibilities.
Clear evaluation of incidents, reportability, and escalation requirements.
Periodic analysis of complaints, safety signals, and recurring field issues.
Assessment of product or process changes and their regulatory consequences.
Prioritized post-market actions for continued authorization readiness.
LexoraMed provides integrated regulatory support across Saudi Arabia, GCC, and global markets — helping manufacturers move from strategy to authorization with confidence and clarity.
Advisory on securing MDMA, SFDA approvals, and global authorization pathways for regional and international market entry.
Leading comprehensive reviews of innovative device dossiers, successfully translating advanced clinical data, cybersecurity parameters, and biocompatibility profiles into robust regulatory submissions.
Ongoing compliance, vigilance, safety monitoring, reporting, and lifecycle support after market authorization.
Clear answers to the most common regulatory and compliance questions manufacturers ask before entering Saudi Arabia and global markets.